Breakthrough T1D UK

Home > News & events > News > CamAPS Liberty®: behind the headlines News You may have heard of a new feature called ‘CamAPS Liberty’, which will soon be available on the CamAPS FX app. This ‘fully closed-loop’ (FCL) mode, when activated; will allow users to remove the need to count carbohydrates before a meal. But what does this mean for people with type 1 diabetes (T1D), and how close are we to removing meal announcement altogether? Here is what we know: What is ‘Liberty’ by Cam APS?

Home > News & events > News > Three key themes from ATTD 2026 News The Advanced Technologies & Treatments for Diabetes (ATTD) conference took place in Barcelona this year. There were many topics discussed, from artificial intelligence in type 1 diabetes (T1D) management to how technology can help people with T1D play sports. We will be bringing you three key themes that ran throughout the conference – early detection, cellular cures and disease-modifying therapies.

Home > Knowledge & support > Resource hub > “Anyone can be a unicorn rider.” Shared stories Sunday Times bestselling author Annabel Steadman (Skandar series) was diagnosed with type 1 diabetes aged four. She always wondered where she fit into the adventure. “I think I spent quite a lot of my 20s trying to pretend I didn’t want to be a writer.I’d gone to Cambridge to study Russian and Spanish, before switching to a law degree and qualifying.

Campaigning for better treatment Lesley and Neal Davison’s daughter Megan, who had T1DE, died by suicide in 2017, expressing that she felt pushed to end her own life due to the lack of appropriate treatment available at the time. Since then, they’ve been campaigning for better treatment for T1DE patients to prevent future deaths. Lesley said: “We know first-hand how important it is for people with T1DE to be able to receive the right treatment. When our daughter died, we were heartbroken.

Five years of pushing for change At Breakthrough T1D, we were deeply concerned about the extent of T1DE, especially some high profile cases which tragically resulted in premature deaths. We conducted a parliamentary inquiry into T1DE, led by then-MPs Sir George Howarth and the Rt. Hon Theresa May which was published in January 2024. The report highlighted significant gaps in the health system needed to diagnose and treat the condition.

Home > News & events > News > New report identifies ‘disconnect’ in specialist diabetes care for adults with mental health problems News A new report has revealed a critical disconnect between mental health services and specialist diabetes teams, leaving adults who self administer insulin without the coordinated support they need. The report calls for urgent action to close these gaps and protect vulnerable people from avoidable harm.

Home > Knowledge & support > Early detection of type 1 diabetes Type 1 diabetes (T1D) doesn’t begin with symptoms. The immune attack that causes the condition often develops silently for months or years, which is why many people are diagnosed only after becoming seriously unwell. Early detection can change this.

Home > News & events > Fundraising events > London to Brighton Cycle Ride 2026 Cycle rides Cycle the iconic 55-mile route from London to Brighton. About the event The fantastic London to Brighton Cycle is back for 2026! Starting on Clapham Common in South-West London, you’ll ride 55 miles down to the stunning Brighton seafront, where the amazing crowds will cheer you over the finish line.

Home > News & events > News > Six key things to take from this year’s European Association for the Study of Diabetes (EASD) conference Spotlight on beta cell replacement therapies Insulin producing cells (known as beta cells) are destroyed by the immune system in type 1 diabetes (T1D). Finding ways to replace these cells would ultimately achieve Breakthrough T1D’s overall goal: to rid the world of type 1.

Home > News & events > News > Type 1 diabetes diagnoses unaffected by reported lab test errors NHS England has confirmed that some machines used to diagnose and monitor diabetes have produced inaccurate results, affecting people being assessed for type 2 diabetes. We want to reassure everyone living with or affected by type 1 diabetes that the situation is different for T1D.